PAR 0.00% 25.5¢ paradigm biopharmaceuticals limited..

Paradigm Competition, page-7

  1. 1,596 Posts.
    lightbulb Created with Sketch. 166
    Some on here, or at least one regular contributor
    on these threads would claim that induced
    pluripotent stem cells have a very good chance
    as a DMOAD. Currently about midway through
    Phase 3 trials here in Aust.(for knee OA). I no
    longer think they are genuine threat to iPPS, but
    some do.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.